Discontinued — last reported Q4 '21
Viatris Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price decreased by 10.5% to $31.94 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.1%, from $35.54 to $31.94.
Provides context on the cost basis of the company's future equity issuance relative to current market valuations.
This represents the weighted average exercise price for all stock options that are vested or expected to vest. It helps...
Used by analysts to model the potential impact of option exercises on future earnings per share.
other_share_based_compensation_arrangement_by_share_base_01392a| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.37 | $37.40 | $38.21 | $38.43 | $38.62 | $37.20 | $37.31 | $37.55 | $35.90 | $36.12 | $35.99 | $35.54 | $35.88 | $35.68 | $31.94 |
| QoQ Change | — | +0.1% | +2.2% | +0.6% | +0.5% | -3.7% | +0.3% | +0.6% | -4.4% | +0.6% | -0.4% | -1.3% | +1.0% | -0.6% | -10.5% |
| YoY Change | — | — | — | +2.8% | +3.3% | -2.6% | -2.9% | -2.8% | -3.5% | -3.2% | -4.2% | -1.0% | -0.7% | -0.9% | -10.1% |